Expert Asks FDA to Reconsider Powerful Opioid

The FDA’s approval on Friday of a new opioid that’s 10 times more powerful than fentanyl has drawn criticism from the head of the agency’s painkiller advisory committee and others. 

Fentanyl in various forms has been blamed for tens of thousands of overdose deaths in America’s opioid epidemic.

Although the committee approved the new drug Dsuvia by a 10-3 vote, Raeford Brown, its chair, wrote to the agency and asked it to reject the drug. 

The Quote: “I predict that we will encounter diversion, abuse and death within the early months of its availability on the market,” Brown wrote.

The New York Times